The oncology resection devices market is projected to grow from USD 6.7 billion in 2026 to USD 15.1 billion by 2036, at a CAGR of 8.5%. Electrosurgical devices will dominate with a 40.0% market share, while solid tumors will lead the application segment with a 70.0% share.